Eli Lilly is developing retatrutide
Some studies suggest that it may be more effective than Semaglutide, particularly in weight reduction
If you experience the following symptoms after administering retatrutide, immediately visit the nearby healthcare facility to get urgent medical attention: Skin rash Itching Swelling of the face, lips, tongue, or throat Difficulty breathing Shortness of breath Wheezing Dizziness Rapid and irregular heartbeat Nausea Vomiting Abdominal discomfort In severe cases, hypersensitivity reactions can cause a sudden drop in blood pressure, which requires immediate medical attention
It is expected to be in the market by 2026 or 2027
If reactions persist beyond 3-4 days or progressively worsen despite conservative management, medical evaluation is warranted
Substantial evidence demonstrates the relationship between diabetes and cognitive dysfunction